Case Details
Citation
DIAGCOR BIOSCIENCE INCORPORATION LTD AND ANOTHER v. ZENDEX BIO STRATEGY INCORPORATED AND OTHERS, HCA 2733/2015
Case Number
HCA 2733/2015
Court
Court of First Instance
(CFI)
Decision Date
10 August 2018
Parties
Applicant(s):

DIAGCOR BIOSCIENCE INCORPORATION LIMITED (達雅高生物科技有限公司), GUANGZHOU DIAGCOR CLINICAL LABORATORY CO. LTD. (廣州百皋醫學檢驗所有限公司)

Respondent(s):

ZENDEX BIO STRATEGY INCORPORATED, CHAN WING SIN, CHRISTOPHER(陳永善), LIANG YUWEI(梁于薇)

For Applicant(s):

note that the auditing practice of the plaintiffs during the period referred to by D2 has never been previously raised either on pleadingsor otherwise, and interrogatories have never been administered in that regard. I note that in his statement of 2 September 2016, at paragraph 4 thereof, Mr Matthew Au; discovery of those documents been sought, they would have been ordered. The discoverability of those documents would have to be properly considered. I am raising merely the fact that on the face of things discovery has not even been sought. I further note that the name of the accounting firm is not provided, and Simon Kam and Jerry Chen are not witnesses to these proceedings. I further note Ms Siu’s submissions

DIAGCOR BIOSCIENCE INCORPORATION LTD AND ANOTHER v. ZENDEX BIO STRATEGY INCORPORATED AND OTHERS

[2018] HKCFI 1929

Court of First Instance10 August 2018

Citation

Court

Procedural posture

Issues

Holdings

Legal principles

Disposition

Key citations

Appeal history

  1. DIAGCOR BIOSCIENCE INCORPORATION LTD AND ANOTHER v. ZENDEX BIO STRATEGY INCORPORATED AND OTHERS

    CFI · 10 Aug 2018 · [2018] HKCFI 1929

    This judgment